Author Topic: Anti-SAP drug - Phase 2  (Read 4258 times)

ziad_okeil

  • *
  • Posts: 49
  • Reason for joining: AL Amyloidosis - skin/Soft tissue involvement
  • Diagnosed: 03/2013
Anti-SAP drug - Phase 2
« on: October 19, 2015, 06:44:50 am »
Good morning Miriam,

I was wondering whether you have any info about the start date of phase 2 trial of the Anti-SAP drug?
2015 is coming to an end soon and still there is no official date/info announced by the NAC.

Thanks
regards,
Ziad

Miriam Vered

  • Administrator
  • *****
  • Posts: 554
Re: Anti-SAP drug - Phase 2
« Reply #1 on: October 23, 2015, 10:31:21 am »
Hi Ziad,


This is Professor Sir Mark Pepys' answer to your question:
The phase II study is currently being planned with the intention of starting in 2016. The intervention, the disease and the regulatory environment are all very complex so that the process is unavoidably slow. GSK will make the official announcement on the clinicaltrials.gov website when the trial opens. At the same time the NAC will be recruiting patients.


There is also an official joint statement from the NAC and GSK that is provided in answer to patient enquiries. I will post it here soon.


I hope that helps.

ziad_okeil

  • *
  • Posts: 49
  • Reason for joining: AL Amyloidosis - skin/Soft tissue involvement
  • Diagnosed: 03/2013
Re: Anti-SAP drug - Phase 2
« Reply #2 on: October 23, 2015, 12:14:04 pm »
Thanks Miriam!
Ziad